175 related articles for article (PubMed ID: 15500000)
1. Carbonic anhydrase inhibitors: aliphatic N-phosphorylated sulfamates--a novel zinc-anchoring group leading to nanomolar inhibitors.
Bonnac L; Innocenti A; Winum JY; Casini A; Montero JL; Scozzafava A; Barragan V; Supuran CT
J Enzyme Inhib Med Chem; 2004 Jun; 19(3):275-8. PubMed ID: 15500000
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase inhibitors: inhibition of transmembrane, tumor-associated isozyme IX, and cytosolic isozymes I and II with aliphatic sulfamates.
Winum JY; Vullo D; Casini A; Montero JL; Scozzafava A; Supuran CT
J Med Chem; 2003 Dec; 46(25):5471-7. PubMed ID: 14640555
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV.
Casini A; Antel J; Abbate F; Scozzafava A; David S; Waldeck H; Schäfer S; Supuran CT
Bioorg Med Chem Lett; 2003 Mar; 13(5):841-5. PubMed ID: 12617904
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with bis-sulfamates.
Winum JY; Pastorekova S; Jakubickova L; Montero JL; Scozzafava A; Pastorek J; Vullo D; Innocenti A; Supuran CT
Bioorg Med Chem Lett; 2005 Feb; 15(3):579-84. PubMed ID: 15664816
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of novel pyrazoline-based aromatic sulfamates with potent carbonic anhydrase isoforms II, IV and IX inhibitory efficacy.
Nocentini A; Moi D; Balboni G; Salvadori S; Onnis V; Supuran CT
Bioorg Chem; 2018 Apr; 77():633-639. PubMed ID: 29502024
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors.
Winum JY; Vullo D; Casini A; Montero JL; Scozzafava A; Supuran CT
J Med Chem; 2003 May; 46(11):2197-204. PubMed ID: 12747791
[TBL] [Abstract][Full Text] [Related]
7. Discovery of thiazolin-4-one-based aromatic sulfamates as a new class of carbonic anhydrase isoforms I, II, IV, and IX inhibitors.
Nocentini A; Moi D; Balboni G; Onnis V; Supuran CT
Bioorg Chem; 2018 Apr; 77():293-299. PubMed ID: 29421705
[TBL] [Abstract][Full Text] [Related]
8. In vitro inhibition of α-carbonic anhydrase isozymes by some phenolic compounds.
Oztürk Sarikaya SB; Topal F; Sentürk M; Gülçin I; Supuran CT
Bioorg Med Chem Lett; 2011 Jul; 21(14):4259-62. PubMed ID: 21669522
[TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with N-hydroxysulfamides--a new zinc-binding function in the design of inhibitors.
Winum JY; Innocenti A; Nasr J; Montero JL; Scozzafava A; Vullo D; Supuran CT
Bioorg Med Chem Lett; 2005 May; 15(9):2353-8. PubMed ID: 15837324
[TBL] [Abstract][Full Text] [Related]
10. Sulfamates of methyl triterpenoates are effective and competitive inhibitors of carbonic anhydrase II.
Schwarz S; Sommerwerk S; Lucas SD; Heller L; Csuk R
Eur J Med Chem; 2014 Oct; 86():95-102. PubMed ID: 25147151
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship with pyrazoline-based aromatic sulfamates as carbonic anhydrase isoforms I, II, IX and XII inhibitors: Synthesis and biological evaluation.
Moi D; Nocentini A; Deplano A; Balboni G; Supuran CT; Onnis V
Eur J Med Chem; 2019 Nov; 182():111638. PubMed ID: 31472471
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase inhibitors. Comparison of aliphatic sulfamate/bis-sulfamate adducts with isozymes II and IX as a platform for designing tight-binding, more isoform-selective inhibitors.
Vitale RM; Alterio V; Innocenti A; Winum JY; Monti SM; De Simone G; Supuran CT
J Med Chem; 2009 Oct; 52(19):5990-8. PubMed ID: 19731956
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase inhibitors. Synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with boron-containing sulfonamides, sulfamides, and sulfamates: toward agents for boron neutron capture therapy of hypoxic tumors.
Winum JY; Cecchi A; Montero JL; Innocenti A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Jul; 15(13):3302-6. PubMed ID: 15908201
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and carbonic anhydrase inhibitory activities of new thienyl-substituted pyrazoline benzenesulfonamides.
Mete E; Comez B; Inci Gul H; Gulcin I; Supuran CT
J Enzyme Inhib Med Chem; 2016; 31(sup2):1-5. PubMed ID: 27435177
[TBL] [Abstract][Full Text] [Related]
15. The human carbonic anhydrase isoenzymes I and II (hCA I and II) inhibition effects of trimethoxyindane derivatives.
Taslimi P; Gulcin I; Ozgeris B; Goksu S; Tumer F; Alwasel SH; Supuran CT
J Enzyme Inhib Med Chem; 2016; 31(1):152-7. PubMed ID: 25697270
[TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1,3,4-thiadiazole- and 1,2,4-triazole-thiols.
Almajan GL; Innocenti A; Puccetti L; Manole G; Barbuceanu S; Saramet I; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 May; 15(9):2347-52. PubMed ID: 15837323
[TBL] [Abstract][Full Text] [Related]
17. Effects of dopaminergic compounds on carbonic anhydrase isozymes I, II, and VI.
Sentürk M; Ekinci D; Göksu S; Supuran CT
J Enzyme Inhib Med Chem; 2012 Jun; 27(3):365-9. PubMed ID: 21699374
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
[TBL] [Abstract][Full Text] [Related]
20. Pyridazinone substituted benzenesulfonamides as potent carbonic anhydrase inhibitors.
Yaseen R; Ekinci D; Senturk M; Hameed AD; Ovais S; Rathore P; Samim M; Javed K; Supuran CT
Bioorg Med Chem Lett; 2016 Feb; 26(4):1337-41. PubMed ID: 26804228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
